Sinon Therapeutics
Durham
About Sinon Therapeutics
SiNON is dedicated to improving the lives of those who suffer from debilitating neurological diseases by increasing the ability of drugs to cross the Blood Brain Barrier (BBB).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $50.0K
- Funding stage: Seed
- Last round: Debt Financing (Oct 2020)
- Website: sinontx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/sinon-therapeutics-125286 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.